av/aurobindo--big.svg

COM:AUROBINDO

Aurobindo Pharma

  • Stock

Last Close

1,220.00

22/11 09:59

Market Cap

772.21B

Beta: -

Volume Today

494.22K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
21.46B
-
29.89B
39.33%
38.50B
28.78%
42.09B
9.34%
50.94B
21.03%
65.52B
28.61%
74.73B
14.05%
83.63B
11.92%
82.90B
0.87%
80.33B
3.11%
average payables
11.60B
-
17.01B
46.66%
22.89B
34.55%
25.08B
9.55%
25.58B
2.01%
26.52B
3.69%
26.11B
1.55%
26.70B
2.25%
27.49B
2.96%
32.87B
19.58%
average receivables
24.40B
-
35.08B
43.79%
44.77B
27.61%
44.98B
0.46%
44.50B
1.05%
53.90B
21.12%
51.75B
4.00%
40.56B
21.62%
40.92B
0.88%
45.48B
11.16%
book value per share
64.38
-
88.36
37.24%
120.80
36.72%
143.38
18.69%
199.36
39.04%
237.08
18.92%
286.90
21.01%
374.27
30.45%
419.43
12.07%
458.12
9.23%
capex per share
-6.70
-
-13.17
96.41%
-26.84
103.89%
-28.95
7.84%
-26.11
9.80%
-27.40
4.93%
-24.42
10.86%
-31.98
30.94%
-46.16
44.34%
-46.43
0.60%
capex to depreciation
-1.25
-
-2.31
84.88%
-3.99
72.92%
-3.96
0.81%
-2.74
30.79%
-2.40
12.34%
-1.48
38.41%
-1.78
19.93%
-2.40
35.23%
-2.19
8.96%
capex to operating cash flow
-0.60
-
-0.62
2.81%
-0.89
43.47%
-0.52
42.02%
-0.78
51.46%
-0.99
26.46%
-0.33
67.00%
-0.56
72.33%
-0.54
4.22%
-1.14
111.41%
capex to revenue
-0.05
-
-0.06
31.33%
-0.11
80.09%
-0.12
0.56%
-0.09
18.25%
-0.08
11.59%
-0.06
24.63%
-0.08
21.23%
-0.12
51.70%
-0.11
4.53%
cash per share
3.07
-
8.35
172.47%
14.26
70.68%
8.75
38.65%
21.17
142.06%
32.92
55.48%
48.51
47.34%
95.93
97.78%
77.78
18.92%
111.38
43.20%
days of inventory on hand
239.64
-
239.42
0.09%
242.33
1.22%
245.66
1.37%
316.66
28.90%
303.54
4.14%
288.69
4.89%
332.71
15.25%
271.90
18.28%
275.08
1.17%
days payables outstanding
136.77
-
135.98
0.57%
149.78
10.15%
141.15
5.76%
142.02
0.61%
112.15
21.03%
95.42
14.92%
103.01
7.96%
97.30
5.55%
125.12
28.60%
days sales outstanding
134.99
-
122.55
9.22%
131.31
7.15%
101.67
22.57%
108.51
6.73%
113.23
4.35%
70.38
37.84%
55.39
21.30%
69.61
25.66%
68.80
1.16%
debt to assets
0.40
-
0.34
13.22%
0.30
13.10%
0.21
30.87%
0.23
9.17%
0.26
16.52%
0.22
17.28%
0.16
24.74%
0.10
41.04%
0.13
37.10%
debt to equity
1.01
-
0.86
14.11%
0.67
22.82%
0.40
39.83%
0.41
1.86%
0.50
22.81%
0.37
25.26%
0.25
32.49%
0.13
47.28%
0.20
47.62%
dividend yield
0.00
-
0.00
-
0.00
6.49%
0.01
119.15%
0.00
50.23%
0.01
130.63%
0.00
37.45%
0.01
48.36%
0.01
115.11%
earnings yield
0.08
-
0.04
43.84%
0.05
3.02%
0.06
27.88%
0.07
19.83%
0.05
27.02%
0.12
129.58%
0.10
11.66%
0.07
34.56%
0.06
6.07%
enterprise value
184.88B
-
396.25B
114.33%
473.83B
19.58%
423.90B
10.54%
382.92B
9.67%
515.36B
34.59%
277.46B
46.16%
518.15B
86.75%
382.89B
26.10%
312.44B
18.40%
enterprise value over ebitda
9.27
-
14.98
61.63%
14.73
1.73%
11.87
19.40%
9.85
17.05%
12.81
30.13%
5.64
56.00%
9.63
70.89%
8.29
13.99%
7.82
5.68%
ev to operating cash flow
28.61
-
32.04
11.99%
26.93
15.95%
12.93
51.99%
19.59
51.50%
31.77
62.20%
6.33
80.07%
15.57
145.79%
7.63
50.96%
13.09
71.50%
ev to sales
2.30
-
3.29
43.06%
3.47
5.51%
2.89
16.73%
2.36
18.23%
2.68
13.40%
1.22
54.48%
2.11
72.91%
1.64
22.34%
1.27
22.55%
free cash flow per share
4.39
-
8.03
82.84%
3.28
59.19%
27.07
726.23%
7.25
73.21%
0.28
96.09%
50.35
17,649.91%
24.83
50.68%
39.46
58.88%
-5.69
114.43%
free cash flow yield
0.02
-
0.01
23.44%
0.00
66.54%
0.04
811.52%
0.01
69.48%
0.00
97.07%
0.12
33,941.24%
0.03
76.88%
0.06
109.44%
-0.01
118.63%
graham net net
-36.43
-
-41.25
13.24%
-34.63
16.04%
-36.15
4.38%
-28.02
22.51%
-43.30
54.56%
-36.44
15.84%
17.15
147.05%
39.75
131.82%
20.88
47.48%
graham number
170.78
-
231.70
35.67%
303.68
31.06%
356.21
17.30%
430.73
20.92%
464.00
7.72%
558.46
20.36%
875.62
56.79%
653.08
25.42%
582.34
10.83%
income quality
0.42
-
0.57
35.29%
0.65
13.28%
1.07
65.73%
0.60
43.69%
0.52
13.00%
1.17
123.08%
0.45
61.27%
1.49
228.11%
0.91
38.58%
intangibles to total assets
0.02
-
0.07
179.13%
0.06
16.02%
0.06
7.76%
0.09
55.94%
0.12
26.01%
0.11
3.89%
0.09
18.38%
0.11
15.59%
0.10
7.70%
interest coverage
20.00
-
32.83
64.11%
36.10
9.98%
55.81
54.57%
51.95
6.91%
21.94
57.77%
27.92
27.26%
72.57
159.89%
94.86
30.71%
19.60
79.34%
interest debt per share
66.32
-
77.49
16.85%
81.85
5.62%
58.42
28.63%
82.49
41.21%
121.48
47.27%
109.96
9.48%
95.73
12.94%
56.59
40.89%
92.63
63.68%
inventory turnover
1.52
-
1.52
0.09%
1.51
1.20%
1.49
1.36%
1.15
22.42%
1.20
4.32%
1.26
5.14%
1.10
13.23%
1.34
22.37%
1.33
1.16%
invested capital
1.01
-
0.86
14.11%
0.67
22.82%
0.40
39.83%
0.41
1.86%
0.50
22.81%
0.37
25.26%
0.25
32.49%
0.13
47.28%
0.20
47.62%
market cap
148.97B
-
356.41B
139.25%
435.14B
22.09%
395.14B
9.19%
347.16B
12.14%
464.24B
33.72%
242.08B
47.85%
516.39B
113.31%
391.73B
24.14%
303.54B
22.51%
net current asset value
-828.20M
-
5.66B
783.47%
14.18B
150.58%
13.50B
4.83%
27.65B
104.82%
28.03B
1.36%
42.97B
53.32%
78.99B
83.83%
87.75B
11.10%
85.08B
3.05%
net debt to ebitda
1.80
-
1.51
16.34%
1.20
20.17%
0.81
33.02%
0.92
14.14%
1.27
38.23%
0.72
43.43%
0.03
95.44%
-0.19
683.20%
0.22
216.43%
net income per share
20.13
-
27.00
34.12%
33.93
25.64%
39.33
15.92%
41.36
5.16%
40.36
2.42%
48.32
19.71%
91.05
88.45%
45.20
50.36%
32.90
27.20%
operating cash flow per share
11.10
-
21.20
91.04%
30.12
42.11%
56.02
85.99%
33.37
40.44%
27.68
17.03%
74.77
170.10%
56.81
24.02%
85.61
50.69%
40.74
52.42%
payables turnover
2.67
-
2.68
0.58%
2.44
9.21%
2.59
6.11%
2.57
0.61%
3.25
26.63%
3.83
17.54%
3.54
7.37%
3.75
5.87%
2.92
22.24%
receivables turnover
2.70
-
2.98
10.16%
2.78
6.67%
3.59
29.16%
3.36
6.30%
3.22
4.17%
5.19
60.88%
6.59
27.07%
5.24
20.42%
5.31
1.17%
research and ddevelopement to revenue
0.00
-
0.00
231.78%
0.00
47.48%
0.00
2.48%
0.00
59.53%
0.00
118.08%
0.01
36.16%
0.00
47.69%
0.00
0.35%
0.00
42.52%
return on tangible assets
0.13
-
0.13
3.21%
0.13
2.31%
0.15
12.71%
0.13
15.95%
0.10
20.01%
0.11
8.92%
0.17
57.34%
0.09
49.66%
0.05
38.67%
revenue per share
138.00
-
206.38
49.55%
233.66
13.22%
250.57
7.24%
276.49
10.34%
328.14
18.68%
388.06
18.26%
419.12
8.00%
398.79
4.85%
420.18
5.37%
roe
0.31
-
0.31
2.28%
0.28
8.10%
0.27
2.34%
0.21
24.37%
0.17
17.94%
0.17
1.08%
0.24
44.45%
0.11
55.71%
0.07
33.35%
roic
0.19
-
0.18
7.79%
0.18
0.84%
0.19
9.93%
0.15
23.81%
0.12
18.41%
0.13
5.24%
0.11
11.42%
0.10
14.15%
0.06
35.53%
sales general and administrative to revenue
0.01
-
0.02
78.48%
0.02
11.71%
0.02
16.53%
0.03
11.89%
0.02
12.64%
0.03
29.70%
0.03
17.53%
0.03
18.06%
0.03
2.50%
shareholders equity per share
64.38
-
88.36
37.24%
120.80
36.72%
143.38
18.69%
199.36
39.04%
237.08
18.92%
286.90
21.01%
374.27
30.45%
419.43
12.07%
458.12
9.23%
stock based compensation to revenue
-0.00
-
0.00
106.47%
tangible asset value
35.51B
-
43.29B
21.89%
62.45B
44.28%
74.22B
18.84%
97.15B
30.90%
107.85B
11.01%
135.45B
25.59%
188.09B
38.87%
209.61B
11.44%
229.30B
9.39%
tangible book value per share
60.97
-
74.18
21.68%
106.91
44.12%
126.82
18.62%
165.81
30.75%
184.07
11.01%
231.16
25.59%
321.01
38.87%
357.73
11.44%
391.39
9.41%
working capital
14.11B
-
21.62B
53.24%
25.26B
16.80%
25.84B
2.31%
35.07B
35.74%
33.22B
5.29%
50.26B
51.30%
91.58B
82.23%
99.67B
8.83%
100.52B
0.85%

All numbers in (except ratios and percentages)